Laurus Labs Ltd.
http://www.lauruslabs.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Laurus Labs Ltd.
MSN Generic Entresto Launch In Doubt After US Appeals Court Stops Approval
MSN Laboratories will be unable to move forward with any potential ‘at-risk’ launch for its generic version of Novartis’ Entresto blockbuster in the US for now after the originator won a stay of the firm’s ANDA approval pending appeal from the US Court of Appeals for the District of Columbia Circuit.
Novartis Takes Fight To The FDA After US Entresto Generic Approval
Novartis continues to fight tooth and nail to protect its $3bn Entresto brand in the US following the latest FDA approval of a generic version.
Alphabet To AI Connect, What Favors Drug Development At Indian Institutes Of Technology
After starring in India’s first CAR-T treatment, the country’s Indian Institutes of Technology, or IITs, are set to expand their drug development footprint. Scrip takes a look at what the Indian equivalents of the Massachusetts Institute of Technology have going for them, including sizeable funding and alumni like Alphabet's CEO.
Krka To Plant Its Flag In India With Laurus Labs JV
Delivering record annual sales and profits according to preliminary financial results, Slovenia’s Krka will soon look to set up shop in India via a new company established with local big player Laurus Labs.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice